Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Evora

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Arquivos Brasileiros De Cardiologia|July 1, 1993
[The scientific impact of the nitric oxide discovery as vasodilator and endogenous antithrombotic agent]P R Evora
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?P R Evora
International Journal of Cardiology|August 5, 2000
An open discussion about endothelial dysfunction: is it timely to propose a classification?P R Evora
Critical Care Medicine|October 1, 1985
Treatment of hypochloremic metabolic alkalosis by rectal infusion of calcium chlorideP R Evora
Arquivos Brasileiros De Cardiologia|September 17, 1999
The role of G-proteins in the pathophysiology of the cardiovascular diseasesP R Evora, F Nobre
Arquivos Brasileiros De Cardiologia|October 8, 1999
Atrial infarction is a unique and often unrecognized clinical entityR G Mendes, P R Evora
Arquivos Brasileiros De Cardiologia|April 1, 1986
[Long-term course of congenital heart disease after surgical treatment]P R Evora, P J Ribeiro
Arquivos Brasileiros De Cardiologia|June 1, 1995
[Percutaneous transluminal coronary angioplasty and myocardial revascularization. Current status and role of clinical trials]C J Mullany, P R Evora
Arquivos Brasileiros De Cardiologia|September 1, 2000
Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseasesF Viaro, F Nobre, P R Evora
Educacion Medica Y Salud|January 1, 1986
[Learning in intensive therapy, Ribeirão Preto, São Paulo, Brazil]P R Evora, C L dos Reis
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Arquivos Brasileiros De Cardiologia|July 1, 1993
[The scientific impact of the nitric oxide discovery as vasodilator and endogenous antithrombotic agent]P R Evora
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?P R Evora
International Journal of Cardiology|August 5, 2000
An open discussion about endothelial dysfunction: is it timely to propose a classification?P R Evora
Critical Care Medicine|October 1, 1985
Treatment of hypochloremic metabolic alkalosis by rectal infusion of calcium chlorideP R Evora
Arquivos Brasileiros De Cardiologia|September 17, 1999
The role of G-proteins in the pathophysiology of the cardiovascular diseasesP R Evora, F Nobre
Arquivos Brasileiros De Cardiologia|October 8, 1999
Atrial infarction is a unique and often unrecognized clinical entityR G Mendes, P R Evora
Arquivos Brasileiros De Cardiologia|April 1, 1986
[Long-term course of congenital heart disease after surgical treatment]P R Evora, P J Ribeiro
Arquivos Brasileiros De Cardiologia|June 1, 1995
[Percutaneous transluminal coronary angioplasty and myocardial revascularization. Current status and role of clinical trials]C J Mullany, P R Evora
Arquivos Brasileiros De Cardiologia|September 1, 2000
Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseasesF Viaro, F Nobre, P R Evora
Educacion Medica Y Salud|January 1, 1986
[Learning in intensive therapy, Ribeirão Preto, São Paulo, Brazil]P R Evora, C L dos Reis
Pageof 7